All In Biotech

Drug Trial Radar · NCT03197766

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

Last checked: Nov 19, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Dec 12, 2016

Primary completion

Oct 30, 2019

Study completion Oct 30, 2019

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Jun 23, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 5 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The intent and design of this Phase 3 study is to assess BMN 111 as a therapeutic option for the treatment of children with Achondroplasia.

Conditions

  • Achondroplasia

Interventions

  • BMN 111Drug

    Subcutaneous injection of 15 μg/kg of BMN 111 daily

  • PlaceboDrug

    Subcutaneous injection of 15 μg/kg of placebo daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Annualized Growth Velocity (AGV) at Week 52Time frame: At Baseline and Week 52

Locations

24 sites in 7 countries. Site status is shown where the registry gives one.

  • Children's Hospital & Research Center Oakland

    Oakland, California

  • Harbor - UCLA Medical Center

    Torrance, California

  • Alfred I. duPont Hospital for Children

    Wilmington, Delaware

  • Emory University

    Decatur, Georgia

  • Ann and Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Johns Hopkins University

    Baltimore, Maryland

  • University of Missouri

    Columbia, Missouri

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Baylor College of Medicine

    Houston, Texas

  • Seattle Children's Hospital

    Seattle, Washington

  • Medical College of Wisconsin, Children's Hospital

    Milwaukee, Wisconsin

  • The Children's Hospital at Westmead

    Westmead, New South Wales, Australia

  • Murdoch Children's Research Institute

    Parkville, Victoria, Australia

  • Otto-von-Guericke Universitaet, Universitaetskinderklinik

    Magdeburg, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Osaka University Hospital

    Osaka, Japan

  • Saitama Children's Medical Center

    Saitama, Japan

  • Tokushima University Hospital

    Tokushima, Japan

  • Institut Catala de Traumatologica I Medicina de l'Esport

    Barcelona, Spain

  • Hospital Sant Joan de Deu

    Barcelona, Spain

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain

  • Acibadem University School of Medicine

    Istanbul, Turkey (Türkiye)

  • Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital

    London, United Kingdom

  • Sheffield Children's NHS Foundation Trust

    Sheffield, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.